Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis

Hepatology Research

Volumn 37, Issue 8, 2007, Pages 598-607

  Watanabe, Norihito ^a   Takashimizu, Shinji ^a   Kojima, Seiichiro ^a   Kagawa, Tatehiro ^a   Nishizaki, Yasuhiro ^a   Mine, Tetsuya ^a   Matsuzaki, Shohei ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bile canaliculus; Drug inducedliver injury; Multidrug resistance protein 2; Prolonged intrahepatic cholestasis; Vanishing bile duct syndrome

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BILIRUBIN; CHINESE DRUG; CHLORPROMAZINE; COLESTYRAMINE; DICLOFENAC; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; MULTIDRUG RESISTANCE PROTEIN 2; NEOMINOPHAGEN C; PREDNISOLONE; PSYCHOTROPIC AGENT; TIOPRONIN; URSODEOXYCHOLIC ACID;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BILE DUCT; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; ELECTRON MICROSCOPY; FEMALE; HALF LIFE TIME; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER TRANSPLANTATION; MALE; MICROSCOPY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION;

EID: 34347349034     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00115.x     Document Type: Article

References (30)

1. Popper H, Schaffner F. Pathophysiology of cholestasis. Hum Pathol 1970; 1: 1-24.
2. Erlinger S. Drug-induced cholestasis. J Hepatol 1997; 26 (Suppl. 1): 1-4.
3. Sherlock S. Overview of chronic cholestatic conditions in adults: terminology and definitions. Clin Liver Dis 1998; 2: 217-33.
4. Larrey D, Erlinger S. Drug-induced cholestasis. Baillieres Clin Gastroenterol 1988; 2: 423-52.
5. Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 1997; 26 (Suppl. 1): 31-5.
6. Degott C, Feldmann G, Larrey D et al. Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductpenia. Hepatology 1992; 15: 244-51.
7. Watanabe S, Phillips MJ. Ca2+ causes active contraction of bile canaliculi: Direct evidence from microinjection studies. Proc Natl Acad Sci USA 1984; 81: 6164-8.
8. Watanabe N, Tsukada N, Smith CR, Edwards V, Phillips MJ. Permeabilized hepatocyte couplets. Adenosine triphosphate-dependent bile canalicular contractions and a circumferential pericanalicular microfilament belt demonstrated. Lab Invest 1991; 65: 203-13.
9. Watanabe N, Tsukada N, Smith CR, Phillips MJ. Motility of bile canaliculi in the living animal: Implications for bile flow. J Cell Biol 1991; 113: 1069-80.
10. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339: 1217-27.
11. Trauner M, Meier PJ, Boyer JL. Molecular regulation of hepatocellular transport system in cholestasis. J Hepatol 1999; 31: 165-78.
12. Trauner M, Arrese M, Soroka CJ et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255-64.
13. Zollner G, Fickert P, Zenz R et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001; 33: 633-46.
14. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-6.
15. Ludwig J, Weisner RH, LaRusso NF. Idiopathic adulthood ductopenia: A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1988; 7: 193-9.
16. Kool M, de Haas M, Scheffer GL et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997; 57: 3537-47.
17. ++ system: A new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998; 51: 506-11.
18. Tsutsui H, Terano Y, Sakagami C, Hasegawa I, Mizoguchi Y, Morisawa S. Drug-specific T-cell derived from patients with drug-induced allergic hepatitis. J Immunol 1992; 149: 706-16.
19. Liu ZX, Kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis 2002; 6: 755-74.
20. Pham BN, Bemuau J, Durand F et al. Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. J Hepatol 2001; 34: 537-47.
21. Mizoguchi Y, Miyajima K, Sakagami Y et al. Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis. Gastroenterol Jpn 1987; 22: 331-6.
22. Hautekeete ML, Horsmans Y, Van Waeyenberge C et al. HLA association of amoxicillin-clavulanate -induced hepatitis. Gastroenterology 1999; 117: 1181-6.
23. Kurosaki M, Takagi H, Mori M. HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin. Dig Dis Sci 2000; 45: 1103-8.
24. Moradpour D, Altorfer J, Flury R et al. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology 1994; 20: 1437-41.
25. Masubuchi Y, Nakayama S, Horie T. Role of mitochondrial permeability transition in diclofenac-induced hepatotoxicity in rats. Hepatology 2002; 35: 544-51.
26. Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet 1987; 2: 493-6.
27. Velayudham LS, Farrell GC. Drug-induced cholestasis. Expert Opin Drug Saf 2003; 2: 287-304.
28. Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation - is it reversible? Transplantation 1991; 51: 1004-10.
29. Milkiewicz P, Chilton AP, Hubscher SG, Elias E. Antidepressant induced cholestasis: Hepatocellular redistribution of multidrug resistant protein (MRP2). Gut 2003; 52: 300-3.
30. Kullak-Ublick GA, Baretton GB, Oswald M, Renner EL, Paumgartner G, Beuers U. Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. Hepatol Res 2002; 23: 78-82.